Free Trial

Amicus Therapeutics (FOLD) SEC Filings & 10K Form

Amicus Therapeutics logo
$9.19 +0.12 (+1.32%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$9.19 0.00 (0.00%)
As of 02/21/2025 04:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Amicus Therapeutics SEC Filings

DateFilerForm TypeView
02/19/2025
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
7:00 PM
Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SCHEDULE 13G/A
02/13/2025
4:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:17 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:19 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:22 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:00 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
9:25 AM
Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SCHEDULE 13G/A
01/13/2025
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:02 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:03 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:04 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:05 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
6:06 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
5:12 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2024
3:43 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:00 PM
Amicus Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
10:37 AM
Amicus Therapeutics (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G
11/14/2024
8:31 AM
Amicus Therapeutics (Subject)
Avoro Capital Advisors LLC (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Amicus Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
11/07/2024
4:49 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
4:03 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
5:23 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:49 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/07/2024
12:24 PM
Amicus Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
10/04/2024
3:05 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:35 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/03/2024
3:19 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/23/2024
4:10 PM
Amicus Therapeutics (Issuer)
Harford Simon N.R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:01 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2024
7:10 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/09/2024
4:01 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
3:22 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:54 PM
Amicus Therapeutics (Issuer)
WHITMAN BURKE W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:44 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:46 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:47 PM
Amicus Therapeutics (Issuer)
Kelly Michael Aaron (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:49 PM
Amicus Therapeutics (Issuer)
Bleil Lynn Dorsey (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Trump doesn’t give a damn (Ad)

Porter Stansberry: “I met with Trump’s biggest backers… they’re scooping up these 10 stocks” I recently met with one of Trump’s longest-serving advisors. We helped put together a plan to help investors capitalize on Trump’s election. And we found out these 10 stocks are the most likely to boom…

Go here now to find out the names of these 10 stocks.
06/07/2024
6:52 PM
Amicus Therapeutics (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:53 PM
Amicus Therapeutics (Issuer)
WHEELER CRAIG A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
6:41 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
3:38 PM
Amicus Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/05/2024
3:35 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:00 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
3:31 PM
Amicus Therapeutics (Filer)
Form DEF 14A
04/24/2024
3:32 PM
Amicus Therapeutics (Filer)
Form DEFA14A
04/16/2024
4:42 PM
Amicus Therapeutics (Issuer)
Prout Samantha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
3:27 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/03/2024
5:14 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2024
4:52 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:12 PM
Amicus Therapeutics (Issuer)
Castelli Jeff (Reporting)
Form 4/A
03/15/2024
6:13 PM
Amicus Therapeutics (Issuer)
Clark David Michael (Reporting)
Form 4/A
03/15/2024
6:14 PM
Amicus Therapeutics (Issuer)
Crowley John F (Reporting)
Form 4/A
03/15/2024
6:15 PM
Amicus Therapeutics (Issuer)
Campbell Bradley L (Reporting)
Form 4/A
03/15/2024
6:10 PM
Amicus Therapeutics (Issuer)
Rosenberg Ellen (Reporting)
Form 4/A
03/11/2024
4:36 PM
Amicus Therapeutics (Issuer)
SBLENDORIO GLENN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:21 PM
Amicus Therapeutics (Issuer)
MCGLYNN MARGARET G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2024
4:22 PM
Amicus Therapeutics (Issuer)
RAAB MICHAEL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2024
4:35 PM
Amicus Therapeutics (Subject)
MCGLYNN MARGARET G (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:39 PM
Amicus Therapeutics (Subject)
Campbell Bradley L (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/01/2024
3:33 PM
Amicus Therapeutics (Subject)
Crowley John F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2024
6:02 AM
Amicus Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:FOLD) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners